Effect of a fourth Haemophilus influenzae type b immunisation in preterm infants who received dexamethasone for chronic lung disease

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 88, Issue 1, 2003, Pages

  Clarke, Paul ^a   Powell, P J ^b   Goldblatt, D ^c   Robinson, M J ^a  

^a HOPE HOSPITAL   (United Kingdom)

^b ROYAL BOLTON HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B POLYSACCHARIDE TETANUS PROTEIN CONJUGATE VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CHRONIC LUNG DISEASE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; INFANT; MALE; PREMATURITY; PRIORITY JOURNAL;

EID: 0037230293     PISSN: 00039888     EISSN: 13592998     Source Type: Journal    
DOI: 10.1136/fn.88.1.f58     Document Type: Article

References (20)

1. Vadheim CM, Ward JI. Epidemiology in developed countries. In: Ellis R, Granoff DM, eds. Development and Clinical Uses of Haemophilus b Conjugate Vaccines. New York: Marcel Decker, 1994:231-45.
2. Booy R, Hodgson SA, Slack MPE, et al. Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91). Arch Dis Child 1993;69:225-8.
3. Slack MPE, Azzopardi HJ, Hargreaves RM, et al. Enhanced surveillance of invasive Haemophilus influenzae disease in England, 1990 to 1996: Impact of conjugate vaccines. Pediatr Infect Dis J 1998; 17:S204-7.
4. Hargreaves RM, Slack MPE, Howard AJ, et al. Changing patterns of invasive Haemophilus influenzae disease in England and Wales after introduction of the Hib vaccine programme. BMJ 1996;312:160-1.
5. Washburn LK, O'Shea TM, Gillis DC, et al. Response to Haemophilus influenzae type b conjugate vaccine in chronically ill premature infants. J Pediatr 1993; 123:791-4.
6. Munoz A, Salvador A, Brodsky NL, et al. Antibody response of low birth weight infants to Haemophilus influenzae type b polyribosylribitol phosphote-outer membrane protein conjugate vaccine. Pediatrics 1995;96:216-19.
7. Kristensen K, Gyhrs A, Lausen B, et al. Antibody response to Haemophilus influenzae type b capsular polysaccharide conjugated to tetanus toxoid in preterm infants. Pediatr Infect Dis J 1996;15:525-9.
8. Robinson MJ, Campbell F, Powell P, et al. Antibody response to accelerated Hib immunisation in preterm infants receiving dexamethasone for chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1999;80:F69-F71.
9. Slack MH, Schapira D, Thwaites RJ, et al. Immune response of premature infants to meningococcal serogroup C and combined diphtheria-tetanus toxoids-acellular pertussis-Haemophilus influenzae type b conjugate vaccines. J Infect Dis 2001;184:1617-20.
10. Salisbury DM, Begg NT, eds. Immunisation Against Infectious Disease. London: HMSO, 1996.
11. Phipps DC, West J, Eby R, et al. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods 1990;135:121-8.
12. Goldblatt D, Pinto Vaz ARJPM, Miller E. Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization. J Infect Dis 1998;177:1112-15.
13. Käyhty H, Peltola H, Karanko V, et al. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
14. Goldblatt D. Immunisation and the maturation of infant immune responses. Dev Biol Stand 1998;95:125-32.
15. D'Angio CT, Maniscalco WM, Pichichero ME. Immunologic response of extremely premature infants to tetanus, Haemophilus influenzae type b, and polio immunizations. Pediatrics 1995;96:18-22.
16. Northern Neonatal Network. Neonatal Formulary, 3rd Edn. London: BMJ Books, 2000:130,243.
17. Heath PT, Booy R, Griffiths H, et al. Clinical and immunological risk factors associated with Haemophilus influenzae type b conjugate vaccine failure in childhood. Clin Infect Dis 2000;31:973-80.
18. Heath PT, Booy R, Azzopardi HJ, et al. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA 2000;284:2334-40.
19. Goldblatt D, Richmond P, Millard E, et al. The induction of immunologic memory after vaccination with Haemophilus influenzae type b conjugate and acellular pertussis-containing diphtheria, tetanus, anal pertussis vaccine combination. J Infect Dis 1999;180:538-41
20. Poolman J, Kaufhold A, De Grave D, et al. Clinical relevance of lower Hib response in DTPa-based combination vaccines. Vaccine 2001;19:2280-5.